Author

Susana F. Rocha

Spanish National Centre for Cardiovascular Research

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Developmental Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Aroa Garcia-CaberoiD· 2 shared Irene García-GónzaleziD· 2 shared Rui BeneditoiD· 2 shared Aimane Danana· 1 shared Fernanda dos Santos de OliveiraiD· 1 shared José Antonio Enrı́queziD· 1 shared Katrien De BockiD· 1 shared Lorena CussóiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Aroa Garcia-CaberoORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintSep 15, 2025

Disrupted astrocyte-endothelial crosstalk drives hemangioblastoma lesions in VHL disease

Macarena De Andrés-Laguillo, Irene García-Gónzalez, Susana F. Rocha…·Rui Benedito

This study shows that loss of Vhl in astrocytes disrupts astrocyte-endothelial crosstalk, leading to hemangioblastoma formation in VHL disease.

DOI 10.1101/2025.09.15.675862

mouseexperimental assay

𝕏 PostBluesky

Developmental BiologybioRxivPreprintJul 31, 2025

Genetic mosaics reveal mechanisms of resistance to VEGF signaling loss during angiogenesis

Irene García-Gónzalez, Susana F. Rocha, Fernanda dos Santos de Oliveira…·Rui Benedito

The paper shows that endothelial cells lacking VEGFR2 adapt and become dominant in veins, enabling VEGF-independent angiogenesis through molecular changes like venousization and upregulation of VEGFR1 and VEGFR3 ligands.

DOI 10.1101/2025.07.31.667893

𝕏 PostBluesky